It can't be a good thing when a CEO resigns without even the pretense of "spending more time with his family." Sprint-Nextel Corporation (NYSE: S) CEO Gary Forsee has been the focus of investor and analyst anger for some time now; on Friday, the Wall Street Journal reported Sprint management was searching for his replacement and recently, he was targeted by activist investor Ralph Whitworth. In September, Eric Buscemi wondered if his time had run out thanks to his Failure to Turnaround. A whole year following the company's purchase of Nextel, integration was still questionable and EBITDA was forecasted to be billions lower than expected.
According to a statement from Sprint, CFO Paul Saleh will serve as interim CEO while the board finds (finishes finding?) a new CEO. Interestingly, Sprint says it is targeting candidates outside the company. And in what seems to be a "might as well dish all our dirt at once" move, Sprint said it was forecasting a third-quarter net loss of 337,000 post-paid subscribers (the ones who have annual contracts and pay their bills each month).
The news was already cheering up investors; after a nasty drop of 51 cents, or 2.68%, to $18.50 on the day, the stock was up in after-hours trading to $19.05; erasing all the day's losses and then some. The company's stock is near a two-year low.
Last updated: February 10, 2012: 09:42 AM
Hot Stocks
DailyFinance Headlines
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
Benzinga Headlines
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
TheFlyOnTheWall.com Headlines
- Omnicom management to meet with JPMorgan
- NetApp volatility elevated into Q3 and growth outlook
- EMRISE and lender amend loan terms; allows dicount payoff up to 30%
- Alexion target raised to $90 from $76 at ThinkEquity
- Actuant management to meet with JPMorgan
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal


Reader Comments (Page 1 of 1)
10-08-2007 @ 7:05PM
Maxcarp said...
Is there anymore to the rumor circulating last week of a possible deal between Sprint and Verizon? I know it sounds pretty far-fetched, given that Sprint is a fairly large entity and it still seems that they haven't fixed all the bugs from the Nextel deal, but to be honest I just don't feel that Sprint is going anywhere at the moment. I found some info on it that suggests they at least have a starting point for negotiations http://www.newsvisual.com/newsvisual/2007/10/sprint-and-veri.html . Has anyone else heard anything? Or was it just one of those rumors that disappears after a day?
10-08-2007 @ 7:35PM
Paul Sparcello said...
Why Sprint is loosing 337,000 customers:
A) Phone selection
B) Bogus upgrade scam (based on RETAIL price)
C) Additional fees to pay bills in store
10-08-2007 @ 7:40PM
Sarah Gilbert said...
Maxcarp, I don't think the rumors have been quashed; Eric Buscemi mentioned that in his post last week. A Verizon/Sprint deal is still very much a possibility.
http://www.bloggingstocks.com/2007/10/04/sprints-gary-forsee-seeing-more-pressure/
10-09-2007 @ 9:03PM
Eye4Sprint said...
Sprint is ill internally. Their business practices are deeply concerning. Small businesses working with Sprint gets hurt severely. Not good. The company has a serious cancer.